Overview

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Status:
Completed
Trial end date:
2015-09-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate long-term safety information of infliximab in patients who have participated in infliximab clinical studies in ulcerative colitis.
Details
Lead Sponsor:
Janssen Research & Development, LLC
Collaborator:
Janssen Biologics BV
Treatments:
Infliximab